This report evaluates the economic and societal impact of the research-based pharmaceutical industry across nine Latin American countries. It assesses direct, indirect, and induced economic contributions, including employment, GDP impact, and investment in clinical research and manufacturing. The report also highlights societal benefits such as improved patient outcomes, workforce development, and corporate social responsibility initiatives. Case studies in cancer and rheumatoid arthritis demonstrate how innovative medicines improve quality of life and productivity. The analysis concludes that the pharmaceutical industry plays a disproportionally positive role in economic growth and healthcare advancement in the region.

Join for free to read